IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-0-387-30107-5_29.html
   My bibliography  Save this book chapter

Stopping a Trial for Futility: The Cooperative New Scandinavian Enalapril Survival Study II

In: Data Monitoring in Clinical Trials

Author

Listed:
  • Steven Snapinn

    (Amgen Inc.)

  • Curt D. Furberg

    (Wake Forest University School of Medicine, Department of Public Health Sciences)

Abstract

The Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) trial was designed to test the hypothesis that enalapril, an angiotensin-converting enzyme inhibitor, would reduce the risk of death in patients with an acute myocardial infarction. A sequential stopping rule that allowed for both early acceptance and early rejection of the null hypothesis, in the spirit of stochastic curtailment, was developed specifically for this trial. Very early in the trial the Data and Safety Monitoring Committee noticed an excess of mortality in the enalapril group. When this trend persisted, the committee first recommended protocol modifications, then termination of recruitment, and finally termination of the trial. The main reason was futility, as well as the possibility of harm, particularly in certain subgroups. This trial provides useful lessons regarding futility analyses, flexible monitoring rules, and the sponsor’s role on both the Data Monitoring Committee and the Steering Committee.

Suggested Citation

  • Steven Snapinn & Curt D. Furberg, 2006. "Stopping a Trial for Futility: The Cooperative New Scandinavian Enalapril Survival Study II," Springer Books, in: David L. DeMets & Curt D. Furberg & Lawrence M. Friedman (ed.), Data Monitoring in Clinical Trials, chapter 0, pages 302-311, Springer.
    • Handle: RePEc:spr:sprchp:978-0-387-30107-5_29
    DOI: 10.1007/0-387-30107-0_29
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-0-387-30107-5_29. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.